Equities

Procyon Corp

PCYN:PKC

Procyon Corp

Actions
  • Price (USD)0.201
  • Today's Change0.00 / 0.00%
  • Shares traded1.20k
  • 1 Year change+11.66%
  • Beta-0.4187
Data delayed at least 15 minutes, as of Nov 11 2024 20:23 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Procyon Corporation operates through its subsidiaries AMERX Health Care Corporation (AMERX) and Sirius Medical Supply, Inc. (Sirius). AMERX develops and markets medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. Its product lines include AMERX, AMERIGEL, HELIX3 Bioactive Collagen, EXTREMIT-EASE Compression Garment and Advantagen Surgical Collagen. AMERX markets a proprietary line of AMERIGEL advanced skin and wound care products made with Oakin, that promote healing in wound and problematic skin conditions, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder (HELIX3 CP) and Collagen Matrix (HELIX3 CM). Its wound care product includes AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Hyrdocolloid Dressing, and AMERX Wound Care Kits.

  • Revenue in USD (TTM)4.98m
  • Net income in USD-312.97k
  • Incorporated1987
  • Employees19.00
  • Location
    Procyon Corp1300 S Highland AveCLEARWATER 33756-6519United StatesUSA
  • Phone+1 (727) 447-2998
  • Fax+1 (727) 447-5617
  • Websitehttps://procyoncorp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PainReform Ltd0.00-17.67m1.26m6.00---------41.92-41.920.00-3.530.00----0.00-309.43-55.47-650.22-68.20---------------------6.28------
Evofem Biosciences Inc17.71m57.36m1.32m37.000.0009--0.02310.0748-0.4918-0.49180.0297-0.78031.571.813.61478,756.80534.21-211.64----75.75--341.16-1,031.550.0841-4.50----8.20--164.08---10.59--
Nexien Biopharma Inc0.00-239.11k1.42m0.00---------0.0036-0.00360.00-0.00510.00-------1,010.82-1,542.27---------------1.87--------33.93------
Mallinckrodt PLC1.96bn917.30m1.60m2.80k----0.00150.000820.1920.2179.8752.210.46411.684.83698,892.9021.76-12.4925.91-15.8533.7735.6846.88-44.381.83-0.01380.6286---2.53-10.31-83.00------
Procyon Corp4.98m-312.97k1.63m19.00--0.7512--0.3274-0.0387-0.03870.61380.28171.472.329.90262,338.40-10.081.19-12.701.4478.0774.40-6.840.86912.41--0.00--6.353.53-367.38--17.32--
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
Bespoke Extracts Inc1.05m-1.15m1.76m10.00------1.68-0.1126-0.11260.1029-0.21362.5715.4320.63104,678.00-280.87------44.94---109.44--0.0643-35.39----22,933.72--63.98------
cbdMD Inc20.64m-23.42m1.77m52.00--0.5845--0.0857-18.95-18.957.850.80550.88172.0120.35396,856.90-82.98-38.59-112.36-41.5063.4363.80-94.12-87.980.5172-3.890.3128---31.77120.9163.64---4.95--
Altamira Therapeutics Ltd59.60k-224.50k1.78m10.000.69280.1988--29.820.67880.67880.03372.370.008-0.19973.365,960.18-2.99-66.27-5.77-113.27150.61---376.67-25,125.900.4268--0.0634------89.86------
60 Degrees Pharmaceuticals Inc441.25k-2.03m1.84m3.001.05----4.180.94550.94550.63362.980.07550.83552.09147,083.30-27.71------15.59---366.89--2.74--0.0505---50.40--35.51------
SOHM Inc-100.00bn-100.00bn1.91m--------------------------------------------------------------
Agentix Corp0.00-326.32k2.00m-----------0.0081-0.00810.00-0.0680.00-------131.20-----------------16.66--------57.41------
InVitro International716.89k6.22k2.01m16.00252.862.75--2.810.00040.00040.04020.03211.15------0.9957.891.098.83----0.86765.90---------5.111.33-87.77-16.14----
Panacea Life Sciences Holdings Inc2.76m-7.67m2.08m40.00------0.7511-0.4554-0.45540.164-0.52550.15371.6210.1369,098.25-42.65-69.04---225.03-139.49-181.62-277.51-505.410.0285-2.124.79--46.59--12.33------
Data as of Nov 11 2024. Currency figures normalised to Procyon Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.